The regenerative injection service of Relievus, a large pain management network, offered across New Jersey and Pennsylvania sites including Atco, New Jersey.
This listing covers the regenerative injection arm of Relievus, a pain management network with around fourteen offices in New Jersey and three in Pennsylvania. The Atco address in this directory, 429 White Horse Pike, is confirmed on the network's location list. The regenerative service has its own website, separate from the main Relievus pain management site, and presents two treatments: platelet rich plasma (PRP, concentrated from the patient's own blood) and what it calls stem cell injection therapy.
The network's own site carries a clear statement that regenerative medicine including platelet rich plasma and stem cell injection therapy is not approved by the United States Food and Drug Administration. That disclosure is worth noting, because it is the kind of information patients often have to search for. It does not mean the treatment is illegal — these procedures are offered widely in the United States — but it does mean the usual regulatory review of safety and effectiveness has not been completed for these uses.
The significant gap is what is actually injected. The pages reviewed do not state the cell type or source: there is nothing saying whether material is taken from the patient's own bone marrow or fat, or bought in as a donor product such as umbilical cord or amniotic tissue. For a treatment sold under the name stem cell therapy, that is the first thing a patient should establish, because the answer determines cost, regulatory status and whether living cells are involved at all. The site also publishes consent and pre- and post-procedure instruction documents, which suggests a structured process, and asking for the consent form in advance would be a sensible way to find out what is proposed.
No individual clinician is named on the pages reviewed, and because the service is delivered across a network, it is not clear which offices perform the injections or who would do them. The site names conditions only in general terms, referring to joint injuries and pointing to separate clinical indication pages. A single telephone number serves the whole network, so it is worth confirming that treatment is actually available at Atco rather than only at larger sites.
The regenerative site names conditions only broadly, referring to joint injuries and directing readers to separate clinical indication pages; a detailed list is not published on the pages reviewed.
The site offers treatment it calls stem cell injection therapy alongside platelet rich plasma, and states plainly that neither is approved by the United States Food and Drug Administration.
No individual clinician is named on the pages reviewed, although the site has a physicians section; who would perform the injection, and at which office, would need to be established directly.
This is a network service rather than a single clinic. The Atco office in this listing is at 429 White Horse Pike, and the network lists around fourteen further New Jersey addresses together with three in Pennsylvania. The pages reviewed give no description of procedure rooms, imaging guidance or cell processing facilities at any individual site, and do not say which offices deliver the regenerative treatments.
No prices are published. Since the site states that these treatments are not approved by the United States Food and Drug Administration, they are very unlikely to be covered by insurance and should be assumed to be self-funded; a written quote should be requested.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.